Back
Black Diamond Therapeutics 10K Form
Buy
59
BDTX
Black Diamond Therapeutics
Last Price:
$3.22
Seasonality Move:
-29.92%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BDTX News And Ratings
See the #1 stock for the next 7 days that we like better than BDTX
BDTX Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $53.4M |
| Price / Cash Flow: | 13.95 |
| Annual Sales: | $2.50 |
| Price / Book: | 1.22 |
Profitability
| EPS (TTM): | 0.06000 |
|---|---|
| Net Income (TTM): | $5.1M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Black Diamond Therapeutics Earnings Forecast
Key Black Diamond Therapeutics Financial Ratios
-
Per Share Earnings over the last 8 years have been positive in 3 years.
Black Diamond Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BDTX |
| CUSIP: | 09203E |
| Website: | blackdiamondtherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 9.24 |
| Quick Ratio: | 9.05 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BDTX Technical Analysis vs Fundamental Analysis
Buy
59
Black Diamond Therapeutics (BDTX)
is a Buy
Is Black Diamond Therapeutics a Buy or a Sell?
-
Black Diamond Therapeutics stock is rated a BuyThe current Black Diamond Therapeutics [BDTX] share price is $3.04. The Score for BDTX is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.